In a USA Today story about the potential of using cannabis to relieve chronic pain, Devan Kansagara, M.D., M.C.R., says the scientific evidence is thin right now. He says, “You’d like to see what happens with these products over a longer period of time ideally. I would like to see that before recommending wholesale to patients.”

In an article about how hospital finances impact the critical shortage of pediatric hospital beds, the fact that Doernbecher implemented crisis standards of care is mentioned.

OHSU is among health systems around the country charging patients for detailed responses to complex health care queries posed via platforms, such as MyChart.

Matthias Merkel, M.D., Ph.D., joins experts from Legacy, Providence and OHA in updating the public about the severe capacity constraints metro health systems continue to face and encouraging individuals to follow the public health measures that proved effective in preventing transmission during the height of the pandemic, thus lowering the number of adults and children requiring hospitalization for RSV, flu and COVID-19.

Crisis standards of care -- OHSU, Legacy, Providence and Kaiser Permanente implement crisis standards of care for adults.

Daniel Streblow, Ph.D., is leading research to develop an antiviral treatment for the chronic, debilitating joint pain that 30% to 40% of people experience after becoming infected with the emerging Chikunguyna virus. Streblow says: “We have the potential to develop an antiviral that could be used to treat millions of people during large Chikungunya outbreaks and prevent long-term disease in people who are persistently affected by this debilitating disease."

OHSU ranks no. 1, Doernbecher Children's Hospital ranks No. 4, the Knight Cancer Institute ranks No. 8, and the Casey Eye Institute ranks No. 10 among the Portland Business Journal's “most admired” health care companies in Oregon for 2022.

In a WebMD article that reveals toys recalled for safety reasons can be purchased online, Ben Hoffman, M.D., says: “There is an assumption by the public that if something is being sold, that it’s safe, that somebody has determined that it’s safe, and it’s gone through some process to ensure that. But the fact of the matter is things, anything can be sold, and the regulatory process ends up being more reactive than proactive, and so things get in the market and, you know, end up in people’s homes without any proof that they’re safe for kids. That to me is especially scary and unfortunate.”

Similar situations are playing out all over, including at OHSU.

Erik Tucker, Ph.D., is named a National Academy Inventors Fellow.